Registration for Endcorine Board Review (EBR) and Clinical Endocrinology Update (CEU) 2019 is now open! EBR and CEU are coming to Seattle, Washington, Sept. 17-21. CEU will also be in Miami, Florida, Sept. 5-7. Register today!
April Thematic Issue
This month we are highlighting the latest updates in neuroendocrinology with a special collection of journal articles, published in 2017—2019. This free online collection features notable basic and clinical findings from our family of journals.
New! Pediatric ESAP 2019-2020
Advance your pediatric endocrinology practice with 100 new cases to test your knowledge and prepare you for the 2019 exam.
New Osteoporosis CPG
Get the latest recommendations on how to promptly diagnose, treat, and provide ongoing care to postmenopausal women to help prevent osteoporosis and reduce the likelihood of fractures.
- Advocacy in Action: EDCs in Europe, E/M Codes, Diabetes Test Strips and more...
- Q&A: Clifford Rosen, MD: Practice Guideline on Pharmacological Treatment of Osteoporosis in Post-Menopausal Women.
- Endocrine Reviews Editor-in-Chief, Daniel J. Drucker, MD, Named 2019 Hamm Prize Laureate
- Dust in the Wind: How Chemicals in Dust Promote Fat Cell Development in Kids—A discussion of her research of tumor suppressor genes, endocrine neoplasias, and why an accurate family history is so important to determine when a cancer screening should be performed.
- Gaining Ground, Losing Weight—According to recent studies published in The Journal of Clinical Endocrinology & Metabolism, researchers are getting a better understanding of obesity and the continuing efforts to combat it.
Join us at Clinical Endocrinology Update (CEU) to keep your practice up-to-date. This year's comprehensive program will provide you with the latest advances and critical issues in clinical endocrinology. This year's program highlights include:
- Drug Holidays: What Patients and What Drugs?
E. Michael Lewiecki, MD (Miami); Joy N. Tsai, MD (Seattle)
- What's New in Obesity Treatment?
Donna H. Ryan, MD
- Safety of Novel Agents in Type 2 Diabetes Management
Carol Wysham, MD
- Prolactinomas: Special Topics
Mark E. Molitch, MD (Miami); Lawrence Katznelson, MD (Seattle)
- Clinical Update on Thyroid and Pregnancy
Elizabeth N. Pearce, MD, MSc
Endocrine Board Review (EBR) is a case-based course and mock exam that serves as an excellent knowledge assessment. This course is ideal for endocrine fellows planning to take the endocrine board exam, practicing physicians preparing to re-certify, and also for those seeking an intensive knowledge assessment. View the full EBR Program.
- May 3 - 5, 2019 | Endocrine and Diabetes Controversies in Adult Primary Care Practice | Brewster, MA, United States
- May 20 - 25, 2019 | Workshop on SEX DIFFERENCES IN BRAIN AND BEHAVIOR IN HEALTH AND DISEASE | Erice, Sicily, Italy
- May 22 - 24, 2019 | 1st International Diabetes Congress Cuba 2019 | Havana, Cuba
In our most recent episode, we continue our special Women in Endocrinology series with a discussion with Rebecca Simmons, MD, on her Endocrinology article about islet dysfunction in intrauterine growth restriction.
Tune into our podcast to stay up-to-date on the latest advances in endocrinology.
Claim CME and MOC Credits with Ease
Please provide your feedback, complete the evaluation and claim your credits or print your certificate of attendance online at the Center for Learning.
We have discussed the evidence linking nucleotide-binding oligomerization domain (NOD)1, an intracellular pattern recognition receptor, to the onset and progression of obesity-induced insulin resistance.
The IPL levels were lower in BWA than WE men with early T2D, and the lack of inverse association with first-phase ISF in BWA men indicates that IPL might be a less important determinant of the development of T2D in BWA than in WE men.
This review summarizes the present knowledge on genetic and epigenetic alterations.